1
findings and the osteoinductive potential of serum from traumatic brain injured (TBI) patients, and to identify putative osteoinductive factors. Methods: Serum and CSF samples were collected from 17 TBI patients with a concomitant femur shaft fracture and from 24 control patients reporting an isolated fracture. On admission all patients were evaluated using the Glasgow Coma Scale (GCS). Standardised X-rays of the fracture were taken on admission and post-surgery, at 6 weeks, 3, 6 and 12 months. Time to union was determined, the callus size measured and its ratio to the shaft diameter calculated. The osteoinductive potential was determined by measuring the in vitro proliferation rate of the human fetal osteoblastic cell line (hFOB 1.19). Subsequently the samples were processed and analysed using a novel proteomic approach, including enrichment of the unknown factor and 2D electrophor- esis. Results: TBI patients had a shorter time to union (p < 0.001) and showed an increased callus formation in both X-ray projections (p < 0.001). TBI specimens induced a higher mean proliferation rate in hFOB cells (p = 0.014). Statistical analysis revealed a correlation between proliferation rates and callus formation (p < 0.05). A negative correlation between proliferation rates and time to union was also evident (p < 0.01). Pearsons’ correlation coefficient demonstrated significant relationships between GCS score, mean callus ratio and proliferation rates. First proteomic results showed clear cut differences on corresponding 2D gels between TBI and control samples. Most important, several protein spots were exclusively present on the 2D gels from TBI patients. Conclusions: This study demonstrates firstly an enhanced fracture healing and callus formation in TBI patients in comparison to patients without TBI and similar fractures, indicating that the traumatic injured brain might release osteoinductive factors. Secondly, there is a strong correlation between the clinical outcome and serum related induction of proliferation of osteo- blastic cells in vitro, indicating that the osteoinductive factor is released into the systemic blood circulation by the injured brain. doi: 10.1016/j.injury.2009.01.061 ORAL–INVITED BREAKOUT 7-2 Clinical practice guidelines A. Delprado Careflight, Westmead, NSW 2145, Australia In the era of evidence-based medicine the ability to move the evidence from the literature to application in clinical practice is proving to be challenging at times. The introduction of evidence- based clinical practice guidelines (CPGs) within trauma care continues to grow. Evidence from other specialties shows as little as 3–10% uptake by clinicians of CPGs in practice. How do we ensure that these CPGs are actually used by clinicians in their daily practice? What makes a CPG successful? How do we engage and get ‘‘buy in’’ from the clinicians and therefore translation of evidence into practice via CPGs? Lessons learnt from the experience gained during the development and introduction of the Institute of Trauma and Injury Management (NSW ITIM) trauma clinical practice guidelines will be discussed in this presentation. doi: 10.1016/j.injury.2009.01.062 ORAL–INVITED BREAKOUT 7-3 Translating research into practice: The role of the Cochrane Collaboration S. Green Australasian Cochrane Centre, Clayton, VIC 3168, Australia Effective translation of research into practice relies on four platforms: 1. Knowledge generation and synthesis to improve access to relevant reliable research. 2. Understanding of current patterns of care and health policy including identification and description of areas of practice not aligned to current research. 3. The development and testing of strategies to bring about practice change and the uptake of research into practice. 4. Building infrastructure and workforce capacity for research use. The Cochrane Collaboration is an international organization which aims to inform healthcare decisions through preparing reliable systematic reviews of healthcare interventions, and ensuring they are relevant and accessible. This provides the first of the four platforms listed above. This presentation will introduce these concepts, explore some current initiatives to make Cochrane reviews more useful, and more used, and present some strategic options for building knowledge transfer and exchange in trauma care. doi: 10.1016/j.injury.2009.01.063 ORAL–INVITED BREAKOUT 8-1 Tissue engineering for repair and regeneration of new tissue W. Morrison Bernard O’Brien Institute of Microsurgery and St Vincent’s Hospital, Fitzroy, VIC 3065, Australia We have developed an in vivo model of tissue engineering, which comprises a non-collapsible chamber and a vascular pedicle. This environment induces an intense angiogenic response and when cells and or matrix materials are seeded into the chamber, they can survive and organise into a specific tissue type. We have successfully induced large volumes of fat to grow as well as muscle, bone, cartilage and organ tissue including heart, pancreas and thymus. doi: 10.1016/j.injury.2009.01.064 ORAL–INVITED BREAKOUT 8-2 Presenter absent – No Abstract doi: 10.1016/j.injury.2009.01.065 Abstracts / Injury, Int. J. Care Injured 40S (2009) S1–S26 S14

Translating research into practice: The role of the Cochrane Collaboration

  • Upload
    s-green

  • View
    217

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Translating research into practice: The role of the Cochrane Collaboration

Abstracts / Injury, Int. J. Care Injured 40S (2009) S1–S26S14

findings and the osteoinductive potential of serum from traumaticbrain injured (TBI) patients, and to identify putative osteoinductivefactors.

Methods: Serum and CSF samples were collected from 17 TBIpatients with a concomitant femur shaft fracture and from 24control patients reporting an isolated fracture. On admission allpatients were evaluated using the Glasgow Coma Scale (GCS).Standardised X-rays of the fracture were taken on admission andpost-surgery, at 6 weeks, 3, 6 and 12 months. Time to union wasdetermined, the callus size measured and its ratio to the shaftdiameter calculated. The osteoinductive potential was determinedby measuring the in vitro proliferation rate of the human fetalosteoblastic cell line (hFOB 1.19). Subsequently the samples wereprocessed and analysed using a novel proteomic approach,including enrichment of the unknown factor and 2D electrophor-esis.

Results: TBI patients had a shorter time to union (p < 0.001) andshowed an increased callus formation in both X-ray projections(p < 0.001). TBI specimens induced a higher mean proliferationrate in hFOB cells (p = 0.014). Statistical analysis revealed acorrelation between proliferation rates and callus formation(p < 0.05). A negative correlation between proliferation ratesand time to union was also evident (p < 0.01). Pearsons’ correlationcoefficient demonstrated significant relationships between GCSscore, mean callus ratio and proliferation rates. First proteomicresults showed clear cut differences on corresponding 2D gelsbetween TBI and control samples. Most important, several proteinspots were exclusively present on the 2D gels from TBI patients.

Conclusions: This study demonstrates firstly an enhancedfracture healing and callus formation in TBI patients in comparisonto patients without TBI and similar fractures, indicating that thetraumatic injured brain might release osteoinductive factors.Secondly, there is a strong correlation between the clinicaloutcome and serum related induction of proliferation of osteo-blastic cells in vitro, indicating that the osteoinductive factor isreleased into the systemic blood circulation by the injured brain.

doi: 10.1016/j.injury.2009.01.061

ORAL–INVITED

BREAKOUT 7-2

Clinical practice guidelines

A. Delprado

Careflight, Westmead, NSW 2145, Australia

In the era of evidence-based medicine the ability to move theevidence from the literature to application in clinical practice isproving to be challenging at times. The introduction of evidence-based clinical practice guidelines (CPGs) within trauma carecontinues to grow. Evidence from other specialties shows as littleas 3–10% uptake by clinicians of CPGs in practice. How do weensure that these CPGs are actually used by clinicians in their dailypractice? What makes a CPG successful? How do we engage andget ‘‘buy in’’ from the clinicians and therefore translation ofevidence into practice via CPGs? Lessons learnt from theexperience gained during the development and introduction ofthe Institute of Trauma and Injury Management (NSW ITIM)trauma clinical practice guidelines will be discussed in thispresentation.

doi: 10.1016/j.injury.2009.01.062

ORAL–INVITED

BREAKOUT 7-3

Translating research into practice: The role of the CochraneCollaboration

S. Green

Australasian Cochrane Centre, Clayton, VIC 3168, Australia

Effective translation of research into practice relies on fourplatforms:

1. K

nowledge generation and synthesis to improve access torelevant reliable research.

2. U

nderstanding of current patterns of care and health policyincluding identification and description of areas of practice notaligned to current research.

3. T

he development and testing of strategies to bring aboutpractice change and the uptake of research into practice.

4. B

uilding infrastructure and workforce capacity for research use.

The Cochrane Collaboration is an international organizationwhich aims to inform healthcare decisions through preparingreliable systematic reviews of healthcare interventions, andensuring they are relevant and accessible. This provides the firstof the four platforms listed above. This presentation will introducethese concepts, explore some current initiatives to make Cochranereviews more useful, and more used, and present some strategicoptions for building knowledge transfer and exchange in traumacare.

doi: 10.1016/j.injury.2009.01.063

ORAL–INVITED

BREAKOUT 8-1

Tissue engineering for repair and regeneration of new tissue

W. Morrison

Bernard O’Brien Institute of Microsurgery and St Vincent’s Hospital,

Fitzroy, VIC 3065, Australia

We have developed an in vivo model of tissue engineering,which comprises a non-collapsible chamber and a vascular pedicle.This environment induces an intense angiogenic response andwhen cells and or matrix materials are seeded into the chamber,they can survive and organise into a specific tissue type. We havesuccessfully induced large volumes of fat to grow as well as muscle,bone, cartilage and organ tissue including heart, pancreas andthymus.

doi: 10.1016/j.injury.2009.01.064

ORAL–INVITED

BREAKOUT 8-2

Presenter absent – No Abstract

doi: 10.1016/j.injury.2009.01.065